A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor ...
Medical Device News Magazine is committed to delivering high‑quality, in‑depth medical device news and biotechnology updates that include expert bylines. Our coverage offers a comprehensive view of ...
If you’ve been working out intending to gain muscle, you probably know it takes time. However, what if you’ve been putting in considerable effort but ...
Aiying Sun, EVP, Quality, Regulatory and Clinical Affairs at AMDI. "Pursuing the FDA's dual 510(k) clearance and CLIA waiver pathway was a deliberate strategy to bring this innovation to market with ...
India has become an increasingly important player in the global pharmaceutical outsourcing landscape. Over the last decade, the country has progressed from being primarily a generic manufacturing ...
Chris Green writes, "I am often asked how AI will transform conducting medical and pharmaceutical inventory. Some have asked me will it replace human workers? Will everything be automated? Is it more ...
Acquisition of new generation extended-dwell catheter and patented insertion system strengthens Vygon’s vascular access leadership and accelerates US expansion Vygon, a leading group specialized in ...
Human physiology is regulated by circadian rhythms that coordinate metabolism, hormone secretion, mitochondrial function, and cellular repair across the 24-hour cycle. Despite this temporal ...
Michael Nagel, Chief Executive Officer of Raydiant Oximetry. "The FDA's authorization to expand enrollment is an important milestone for the program. We look forward to continuing our collaboration ...
This patented breakthrough is the first and only technology to treat dying tissue and regenerate nerves — restoring circulation, reversing chronic wounds, and preventing amputations for patients who ...
Under the agreement, NAMSA will acquire WuXi AppTec facilities in Minnesota and Georgia. NAMSA, a world-leading MedTech testing, clinical and regulatory consulting firm, announced today that it has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results